08Jun
07Jun
CleanFiber gains $5 million in investment as it continues growth
CleanFiber wrapped up a $5 million investment round last month that will support the completion of an expansion to its factory in Blasdell and help fund future growth. Read more >>
06Jun
INVEST Pitch Perfect Spotlight: How OmniLife Health Is Streamlining Organ Transplants
OmniLIfe Health, based in Lexington, Kentucky, won the MedCity News INVEST Pitch Perfect contest on May 23, beating five other payer/provider startups. The company works to streamline workflows for organ transplants. The startup’s key product is called FlowHawk, which improves clinical workflows for complex care — specifically organ transplant and organ failure care (though the company hopes to expand to oncology in the future). The platform helps automate processes including communication (like HIPAA compliant messaging), documentation, billing, reporting and quality....
05Jun
Father’s Day Gift Guide: The Best Travel Products For Frequent-Fliers
This Father’s Day, get dad something he will enjoy using all year, both at home and when he travels. From ergonomic and practical luggage to accessories and gadgets, these are some of the top gift ideas at every price range. Archer Roose canned wine - If you want a convenient gift for beach days, picnics or even to pack for a vacation, Archer Roose canned wine is easier to carry than a glass bottle. It comes in a variety pack...
03Jun
DetraPel: This Advanced Materials Company Builds Environmentally Friendly Packaging Options
DetraPel is known as an advanced materials company that specializes in synthesizing and manufacturing PFAS-Free protective coatings. Last month, DetraPel announced the rebranding of its industrial pillar with the launch of Impermea Materials, an advanced materials coating company. Read more >>
03Jun
Elizabeth Banks Is Starting a Book Club Exclusively for Drinking Wine
“If you’re a female famous person and you don’t have a book club, are you actually famous?” quips Elizabeth Banks, closing the novel in her hands and taking off her glasses. “No! Of course not.” It’s a clip from a promo video introducing her own, not-entirely-traditional venture: The Elizabeth Banks Book Club. But, plot twist, there aren’t actually any books to read in this one—that is, apart from the made-up titles which serve merely as a clever and cheeky wink,...
02Jun
EarthGrid Reaches $1.3M+ on Netcapital, $30M in Total Investments to Revolutionize Infrastructure Industry
EarthGrid, a company dedicated to revolutionizing the infrastructure industry and creating a sustainable future for all, is proud to announce it has achieved a major milestone of surpassing $1.3 million in investments on Netcapital. Outside of NetCapital, EarthGrid has raised approximately $30 million in total. This success is attributed to the hard work and dedication of the EarthGrid team, as well as the support of the company’s investors. With the use of proprietary plasma tunnel-boring technology, EarthGrid aims to create...
02Jun
7 Standout Sustainability Innovations We Covered This Spring
From planetary warming to plastic waste, it's easy to get bogged down in all the bad news out there. But let's not forget that innovators around the world are on the case, doing largely unsung work on a daily basis to scale solutions with the potential to address these challenges head on. A water-based alternative to PFAS - The group of chemicals known as PFAS are ubiquitous in modern life. Young entrepreneur David Zamarin started working to develop PFAS alternatives...
01Jun
Zylö Receives $294,000 NIH Phase I Grant to Advance its Cutaneous Lupus Program
Zylö Therapeutics Inc., developer of the Z-pod® topical delivery platform, has been awarded a two-year $294,000 Small Business Technology Transfer Research (STTR) grant to: (i) demonstrate that a formulation of N-acylethanolamine (AEA or anandamide) loaded into Zylö’s novel Z-pod delivery system is efficacious (and well tolerated) in a new mouse model of cutaneous lupus developed at Yale University, and (ii) conduct preliminary stability studies to prepare for an eventual investigational new drug (IND) application to the FDA. Read more >>
01Jun